Skip to content
Lower risk Medical device recall · FDA · Published August 15, 2025

Mindray BeneVision N1 Patient Monitor Recall: Potential for abnormal alarm pause

Mindray recalls BeneVision N1 Patient Monitors with specific part numbers and software versions due to potential for abnormal alarm pause. Affected units may require correction to prevent monitoring errors.

🇺🇸 FDA recall #Z-2622-2025Medical deviceMindray ›
Take action

Contact the company

Recalling firmMindray DS USA, Inc. dba Mindray North America800 Macarthur Blvd · Mahwah, NJ 07430-2001
✎ GovInfoNow plain-language explainer

What happened, in plain English

Mindray is recalling certain BeneVision N1 Patient Monitors that have specific part numbers and software versions. These units may cause an abnormal alarm pause, which could lead to missed patient alerts. If you own one of these models, you should check your serial numbers and software versions. Read more at govinfonow.com/recall/51605-mindray-benevision-n1-patient-monitor-recall-potential-for-abnormal-alarm.

Source Summary by GovInfoNow · govinfonow.com/recall/51605-mindray-benevision-n1-patient-monitor-recall-potential-for-abnormal-alarm · Updated August 18, 2026 · FDA enforcement record: FDA #Z-2622-2025

Cite this page

“Mindray BeneVision N1 Patient Monitor Recall: Potential for abnormal alarm pause.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/51605-mindray-benevision-n1-patient-monitor-recall-potential-for-abnormal-alarm. Based on FDA recall #Z-2622-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2622-2025%22&limit=1).

Why it’s dangerous

The monitor may activate an abnormal alarm pause, which could cause the device to stop alerting about critical patient conditions. This might lead to missed alerts if the alarm is not functioning properly, but it does not cause physical harm directly.

Who’s affected

Healthcare providers and patients using the BeneVision N1 Patient Monitor with specific part numbers and software versions listed in the recall. The risk is low as the hazard is a potential alarm pause rather than a direct safety hazard.

How to tell if you have this one

Check if your BeneVision N1 Patient Monitor has part numbers 6660E-PA00010 through 6660E-PA00021 or software versions 1.04.00.01 through 1.06.01.01. Also, verify your serial numbers against the list provided in the recall.

  • Brand
    Mindray
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Your Device

    Verify your BeneVision N1 Patient Monitor's part number and software version against the list provided in the recall to determine if it is affected.

  2. Contact Mindray

    If your device is affected, contact Mindray directly for instructions on how to correct the issue.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide - Nationwide distribution and the country of Canada.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 47 days after the firm started it.

1. Firm started the recall: Aug 15, 202512. FDA classified it Class II: Sep 25, 202523. Published in FDA’s Enforcement Report: Oct 1, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2622-2025 (August 15, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2622-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA